Plant viral genes in DNA idiotypic vaccines activate linked CD4+ T-cell mediated immunity against B-cell malignancies

Nature Biotechnology

Volumn 19, Issue 8, 2001, Pages 760-764

  Savelyeva, Natalia ^a   Munday, Rosalind ^a   Spellerberg, Myfanwy B ^a   Lomonossoff, George P ^b   Stevenson, Freda K ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b JOHN INNES CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; DNA; PLANTS (BOTANY); PROTEINS; TUMORS; VACCINES; VIRUSES;

IMMUNOGENICITY;

GENES;

DNA VACCINE; TUMOR ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; GENE FUSION; GENE SEQUENCE; GENETIC CODE; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PLANT VIRUS; PRIORITY JOURNAL; PROTEIN AGGREGATION; T LYMPHOCYTE ACTIVATION; VIRUS GENE;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; LEUKEMIA; LYMPHOMA; MICE; MICE, INBRED C57BL; MULTIPLE MYELOMA; PLANTS; PLASMIDS; RATS; RECOMBINANT FUSION PROTEINS; TETANUS TOXIN; TIME FACTORS; VACCINES, DNA;

ANIMALIA; POTATO VIRUS X; SOLANUM TUBEROSUM;

EID: 0034904301     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/90816     Document Type: Article

References (32)

1. DNA immunization induces protective immunity against B-cell lymphoma
2. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity
3. Selected strategies to augment polynucleotide immunization
4. Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines
5. DNA vaccines against lymphoma. Promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C
6. DNA vaccines with single chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma
7. + T cells
8. CD4+ T cell-mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN-γ receptor expression by non-hematopoietic cells
9. CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effect of IFN-γ
10. Development of a genetically-engineered, candidate polio vaccine employing the self-assembling properties of the tobacco mosaic virus coat protein
11. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus
12. Plant-derived vaccine protects target animals against a viral disease
13. Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines
14. Assembly and movement of a plant virus carrying a green fluorescent protein overcoat
15. Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses
16. Production of a functional single chain antibody attached to the surface of a plant virus
17. Induction of antibodies to plant viral proteins by DNA-based immunization
18. Reconstitution of potato virus X in vitro
19. Circular dichroism studies of papaya mosaic virus coat protein and its polymers
20. DNA vaccines: Immunology, application, and optimization
21. Idiotypic DNA vaccines against B-cell lymphoma
22. Functional cooperation between T helper cell determinants
23. Immunology and autoimmunity studied with viruses
24. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells
25. In vivo priming by DNA occurs predominantly by antigene transfer
26. DNA-based immunization by in vivo transfection of dendritic cells
27. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
28. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
29. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide
30. Genetic vaccination against defined tumour antigens of B-cell malignances
31. Immunoglobulin VH gene sequence analysis of spontaneous murine immunogloburin-secreting B-cell tumours with clinical features of human disease
32. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo